API & Fine Pharmaceutical Manufacturer in India
CPHI China 2024- A Showcase of WBCIL’s Pharmaceutical Breakthroughs
Published on: July 4, 2024

CPHI China 2024- A Showcase of WBCIL’s Pharmaceutical Breakthroughs

CPHI China 2024 event is one of the foremost global events in the pharmaceutical industry. As leading API manufacturer and global exporter, West Bengal Chemical Industries Limited (cGMP, ISO and HACCP certified)) is poised to make a significant impact at CPHI China 2024. Scheduled to take place from June 19-21, 2024, at the Shanghai New International Expo Centre (SNIEC) in China, CPHI Shanghai promises to be a hub of innovation, networking, and business opportunities.

WBCIL’s participation highlights its dedication to excellence and innovation in the chemical and pharmaceutical sectors.

A Legacy of Innovation and Excellence

WBCIL, established in 1962, has built a formidable reputation as a leading manufacturer and supplier of high-quality APIs, fine chemicals, injectable irons, organic molecules, DC grades/premix and also animal nutrition, all manufactured in state-of-the-art facilities compliant with international standards. For last 6 decades, we have consistently demonstrated a commitment to quality, reliability, and innovation. With a robust focus on research and development, WBCIL has continuously evolved to meet the dynamic demands of the global market.

The Significance of CPHI China 2024

CPHI (Convention on Pharmaceutical Ingredients) Shanghai is a premier global event that attracts thousands of exhibitors and visitors from the pharmaceutical industry. It serves as a vital platform for companies to showcase their latest products, technologies, and services, fostering collaboration and innovation across the industry.

Reflecting on WBCIL’s Successful Participation at CPHI China 2024

CPHI China 2024 was an incredible experience for the WBCIL team, marked by meaningful engagements, potential partnerships, and an exploration of the latest innovations in the pharmaceutical industry. As seasoned exhibitors, we were strategically positioned at the heart of this prestigious event, providing an ideal platform to unveil new business opportunities and engage with industry giants.

Throughout the event, we had the pleasure of welcoming prominent attendees and potential partners from around the globe. We hosted representatives from Mansoor Chemicals and Progressive Associates from Pakistan, SB Pharma Solutions, LLC from Germany, and MISAQ Pharmaceuticals from Dubai. Our booth also saw visits from SAMI Pharmaceuticals (Pvt.) Ltd., Pharmapia from South Korea, Pharma Labo from Tunisia, WSD Pharma from China, PT MitraChem from Indonesia, Swiss Pharmaceuticals Pvt. Ltd. from Karachi, Ideal Pharma Peptide GmbH, and Heze PUEN Pharmaceutical from China.

On the second day, our excitement continued as we welcomed various attendees and potential partners including New Life from Vietnam, Hampton Pharma Private Limited from the USA, Tenatra Chemie Private Limited from India, Fundacja Hasco-Lek from Poland, Monachem Specialities LLP from India, Bajwa Group of Companies from Pakistan, SA Group from Dubai, Genuine Industry Co., Ltd. from China, Sino Caring Pharmaceutical Development (Suzhou) Co., Ltd. from China, and The TNN Development Limited – Chemical Dept from China.

Additionally, we engaged with significant attendees such as Genuine Industries Co. Ltd. from China, Toru Corp. from South Korea, Tavinus Pharma from Mongolia, and Neon Chemicals from Pakistan. These interactions underscored the event’s role as a pivotal platform for networking, knowledge exchange, and fostering potential partnerships and growth avenues.

As we conclude our participation in Convention on Pharmaceutical Ingredients China 2024, we extend our heartfelt thanks to everyone who visited us and contributed to the success of our experience. This event has offered an unparalleled opportunity for us to connect with key players in the industry and discover the latest developments. Stay tuned for more exciting updates from WBCIL as we continue to innovate and grow!

Participating in CPHI China 2024 provides WBCIL with an invaluable opportunity to:

Showcase Innovations: Present its latest products and technological advancements to a global audience.

Network with Industry Leaders: Engage with key stakeholders, including pharmaceutical companies, researchers, and policymakers.

Explore Market Trends: Gain insights into the latest trends and developments shaping the pharmaceutical industry.

Forge Strategic Partnerships: Establish new business relationships and explore potential collaborations.

CPHI china 2024

WBCIL’s Showcase at CPHI China 2024

At CPHI China 2024, WBCIL highlighted several of its groundbreaking products and technologies. The company’s booth will feature interactive demonstrations and detailed presentations, providing visitors with a comprehensive understanding of their offerings. Key highlights include:

Advanced APIs: WBCIL will showcase its latest active pharmaceutical ingredients that adhere to the highest standards of purity and efficacy. These APIs are crucial components in the formulation of effective and safe pharmaceuticals.

Innovative Intermediates: We have presented a range of intermediates designed to enhance the efficiency and cost-effectiveness of pharmaceutical manufacturing processes.

Specialty Chemicals: WBCIL has introduced new specialty chemicals tailored for diverse industrial applications, emphasizing their versatility and high performance.

Commitment to Quality and Sustainability

WBCIL’s participation in Convention on Pharmaceutical Ingredients China 2024 underscores its unwavering commitment to quality and sustainability. Our company has invested heavily in research and development to innovate products that not only meet stringent quality standards but also align with global sustainability goals.

Looking Ahead!

As WBCIL prepares for its participation in CPHI China 2024, the company remains focused on its mission to drive innovation and excellence in the chemical and pharmaceutical sectors. By leveraging the opportunities presented by this prestigious event, WBCIL aims to strengthen its position in the global market, forge new strategic partnerships, and contribute to the advancement of the pharmaceutical industry.

As a globally reputed API manufacturer, WBCIL has garnered significant attention and response at CPHI China 2024. This positive event highlights WBCIL’s strong market presence and capability in the API manufacturing sector. The company’s participation in such a prominent event underscores its commitment to reducing dependency on external sources and enhancing its global footprint.


Request Sample